Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.56 |
| ▸ | ATM | Q13315 | 1/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.52 |
| ▸ | POLB | P06746 | 2/20 | 0.52 |
| ▸ | HTT | P42858 | 2/20 | 0.52 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 2/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL229257 | 1.00 | ALDH1A1 (0.56) | ALDH1A1ATMLMNASMN1; SMN2POLB | |
| SCHEMBL227972 | 1.00 | ALDH1A1 (0.56) | ALDH1A1ATMLMNASMN1; SMN2POLB | |
| SCHEMBL69354 | 0.97 | — | — | |
| SCHEMBL224023 | 0.92 | — | — | |
| SCHEMBL24693081 | 0.87 | CA2 (0.50) | ALDH1A1ATMLMNASMN1; SMN2POLB | |
| SCHEMBL11742016 | 0.87 | L3MBTL1 (0.52) | ALDH1A1ATMLMNASMN1; SMN2POLB | |
| SCHEMBL9279972 | 0.86 | ALDH1A1 (0.64) | ALDH1A1LMNASMN1; SMN2POLBHTT | |
| SCHEMBL11844730 | 0.86 | — | — | |
| SCHEMBL8978116 | 0.86 | ALDH1A1 (0.64) | ALDH1A1LMNASMN1; SMN2POLBHTT | |
| SCHEMBL22481550 | 0.82 | HPGD (0.62) | ALDH1A1ATMLMNASMN1; SMN2MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 531 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119874601-A | 3, 3-Dimethyl-1, 2,3, 4-tetrahydro-9H-carbazole derivative and preparation method and application thereof | 山东大学 | 2025-04-25 | — | — | CN | claimed |
| US-20250368608-A1 | SELECTIVE HDAC6 INHIBITOR | ROYAL COLLEGE OF SURGEONS IN IRELAND (IE) | 2025-12-04 | — | — | US | disclosed |
| US-12472166-B2 | Inhibition of mycobacterial type VII secretion | STICHTING VUMC (NL) | 2025-11-18 | — | — | US | disclosed |
| US-20250250283-A1 | COMPOUND CAPABLE OF REGULATING AND CONTROLLING ACTIVITY OF 15-PGDH, AND PREPARATION METHOD THEREFOR | SCINNOHUB PHARMACEUTICAL CO., LTD. (CN) | 2025-08-07 | — | — | US | disclosed |
| US-20250243217-A1 | COMPOSITIONS AND METHODS OF MODULATING SHORT-CHAIN DEHYDROGENASE ACTIVITY | BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | 2025-07-31 | — | — | US | disclosed |
| US-20250206745-A1 | PYRROLOPYRIDAZINE DERIVATIVES AND RELATED USES | NODTHERA LTD (GB) | 2025-06-26 | — | — | US | disclosed |
| EP-4543446-A1 | SUBSTITUTED FUSED BICYCLIC COMPOUNDS AND RELATED METHODS OF TREATMENT | Alkermes, Inc. (US) | 2025-04-30 | — | — | EP | disclosed |
| CN-119874601-A | 3, 3-Dimethyl-1, 2,3, 4-tetrahydro-9H-carbazole derivative and preparation method and application thereof | 山东大学 | 2025-04-25 | — | — | CN | disclosed |
| CN-119768169-A | Substituted fused bicyclic compounds and related methods of treatment | 阿尔克姆斯有限公司 | 2025-04-04 | — | — | CN | disclosed |
| CN-119285617-A | 1,3, 5-Trisubstituted indole derivatives and use thereof | 沈阳药科大学 | 2025-01-10 | — | — | CN | disclosed |
| US-3946044-A | HERBICIDES | VELSICOL CHEMICAL CORPORATION (US) | 1976-03-23 | — | — | US | disclosed |
| US-3946043-A | HERBICIDES | VELSICOL CHEMICAL CORPORATION (US) | 1976-03-23 | — | — | US | disclosed |
| US-3944410-A | Substituted oxadiazolidine dione herbicides | VELSICOL CHEMICAL CORPORATION (US) | 1976-03-16 | — | — | US | disclosed |
| US-3942972-A | Dioxolane substituted α-haloanilides as herbicides | VELSICOL CHEMICAL CORPORATION (US) | 1976-03-09 | — | — | US | disclosed |
| US-3941580-A | N,N-BIS(2-METHOXY-3,6-DICHLORO-BENZOYL-OXYALKYL) ANILINES | VELSICOL CHEMICAL CORPORATION (US) | 1976-03-02 | — | — | US | disclosed |
| US-3940259-A | Dioxane substituted-α-haloanilides as herbicides | VELSICOL CHEMICAL CORPORATION (US) | 1976-02-24 | — | — | US | disclosed |
| US-3933839-A | HERBICIDES | VELSICOL CHEMICAL CORPORATION (US) | 1976-01-20 | — | — | US | disclosed |
| US-3932438-A | HERBICIDES | VELSICOL CHEMICAL CORPORATION (US) | 1976-01-13 | — | — | US | disclosed |
| US-3932410-A | HERBICIDES | VELSICOL CHEMICAL CORPORATION (US) | 1976-01-13 | — | — | US | disclosed |
| US-3931209-A | HERBICIDES | VELSICOL CHEMICAL CORPORATION (US) | 1976-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250368608-A1 | SELECTIVE HDAC6 INHIBITOR | HDAC6, HDAC3, HDAC1 | ALDH1A1 3394/4885ATM 3211/4885LMNA 4049/4885 |
| US-20250206745-A1 | PYRROLOPYRIDAZINE DERIVATIVES AND RELATED USES | IL1B, NLRP3, NLRP1 | ALDH1A1 226/4885ATM 2361/4885LMNA 3535/4885 |
| US-12472166-B2 | Inhibition of mycobacterial type VII secretion | CFTR, ABCB11, ABCC2 | ALDH1A1 1733/4885ATM 3743/4885LMNA 2859/4885 |
| US-20250243217-A1 | COMPOSITIONS AND METHODS OF MODULATING SHORT-CHAIN DEHYDROGENASE ACTIVITY | HPGD, GCDH, HPGDS | ALDH1A1 126/4885ATM 3970/4885LMNA 1481/4885 |
| US-20250250283-A1 | COMPOUND CAPABLE OF REGULATING AND CONTROLLING ACTIVITY OF 15-PGDH, AND PREPARATION METHOD THEREFOR | CYP11B1, CYP51A1, CYP11B2 | ALDH1A1 242/4885ATM 4700/4885LMNA 2280/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.